{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:16:58Z","timestamp":1792729018312,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015652","name":"Barts Charity","doi-asserted-by":"publisher","award":["G-001431"],"award-info":[{"award-number":["G-001431"]}],"id":[{"id":"10.13039\/100015652","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ahj.2023.12.007","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T19:36:42Z","timestamp":1702755402000},"page":"56-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Feasibility of double-blinded, placebo-controlled interventional study for assessing catheter ablation efficacy in persistent atrial fibrillation: Insights from the ORBITA AF feasibility study"],"prefix":"10.1016","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8572-6294","authenticated-orcid":false,"given":"Vijayabharathy","family":"Kanthasamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Zongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Earley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivienne","family":"Monk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Mangiafico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Creta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Aluwhalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohreh","family":"Honarbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul","family":"Dhinoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiraj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ahj.2023.12.007_bib0001","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ahj.2023.12.007_bib0002","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ahj.2023.12.007_bib0003","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1365-2796.2001.00893.x","article-title":"Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics","volume":"250","author":"Frykman","year":"2001","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.ahj.2023.12.007_bib0004","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ahj.2023.12.007_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"10.1016\/j.ahj.2023.12.007_bib0006","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jclinepi.2012.09.002","article-title":"Sample size calculations for pilot randomized trials: a confidence interval approach","volume":"66","author":"Cocks","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"10115","key":"10.1016\/j.ahj.2023.12.007_bib0007","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ahj.2023.12.007_bib0008","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cct.2003.10.016","article-title":"Assessment of blinding in clinical trials","volume":"25","author":"Bang","year":"2004","journal-title":"Control Clin Trials"},{"issue":"6","key":"10.1016\/j.ahj.2023.12.007_bib0009","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1600-0528.2009.00494.x","article-title":"Towards a proposal for assessment of blinding success in clinical trials: up-to-date review","volume":"37","author":"Kolahi","year":"2009","journal-title":"Community Dent Oral Epidemiol"},{"issue":"4","key":"10.1016\/j.ahj.2023.12.007_bib0010","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/sim.4780010412","article-title":"The role of randomization in clinical trials","volume":"1","author":"Armitage","year":"1982","journal-title":"Stat Med"},{"key":"10.1016\/j.ahj.2023.12.007_bib0011","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1745-6215-15-167","article-title":"The challenge of recruiting patients into a placebo-controlled surgical trial","volume":"15","author":"Hare","year":"2014","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.ahj.2023.12.007_bib0012","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1191\/0962280202sm300ra","article-title":"Placebos that harm: sham surgery controls in clinical trials","volume":"11","author":"London","year":"2002","journal-title":"Stat Methods Med Res"},{"issue":"13","key":"10.1016\/j.ahj.2023.12.007_bib0013","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM199909233411312","article-title":"The ethical problems with sham surgery in clinical research","volume":"341","author":"Macklin","year":"1999","journal-title":"N Engl J Med"},{"issue":"9695","key":"10.1016\/j.ahj.2023.12.007_bib0014","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(09)61086-2","article-title":"Challenges in evaluating surgical innovation","volume":"374","author":"Ergina","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ahj.2023.12.007_bib0015","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s002689900649","article-title":"Issues in surgical randomized controlled trials","volume":"23","author":"McLeod","year":"1999","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.ahj.2023.12.007_bib0016","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00392-021-01959-z","article-title":"Patients' attitude towards a sham-controlled trial on pulmonary vein isolation in atrial fibrillation","volume":"111","author":"Uhe","year":"2022","journal-title":"Clin Res Cardiol"},{"issue":"8","key":"10.1016\/j.ahj.2023.12.007_bib0017","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/eurheartj\/eht457","article-title":"Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)","volume":"35","author":"Mont","year":"2014","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ahj.2023.12.007_bib0018","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.hrthm.2017.01.024","article-title":"Could less be more in catheter ablation for persistent atrial fibrillation? Pulmonary vein isolation reconsidered","volume":"14","author":"Buch","year":"2017","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1016\/j.ahj.2023.12.007_bib0019","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11886-015-0631-7","article-title":"The hot and the cold: radiofrequency versus cryoballoon ablation for atrial fibrillation","volume":"17","author":"Ang","year":"2015","journal-title":"Curr Cardiol Rep"},{"issue":"8","key":"10.1016\/j.ahj.2023.12.007_bib0020","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/jce.14414","article-title":"Pulsed field ablation for pulmonary vein isolation in the treatment of atrial fibrillation","volume":"31","author":"Bradley","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"10.1016\/j.ahj.2023.12.007_bib0021","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jacep.2019.04.009","article-title":"Pulmonary vein isolation with very high power, short duration, temperature-controlled lesions: yhe QDOT-FAST trial","volume":"5","author":"Reddy","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.ahj.2023.12.007_bib0022","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jacep.2021.02.014","article-title":"Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II","volume":"7","author":"Reddy","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"10.1016\/j.ahj.2023.12.007_bib0023","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jacc.2019.04.021","article-title":"Pulsed field ablation for pulmonary vein isolation in atrial fibrillation","volume":"74","author":"Reddy","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2023.12.007_bib0024","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.hrthm.2020.04.040","article-title":"Ostial dimensional changes after pulmonary vein isolation: pulsed field ablation vs radiofrequency ablation","volume":"17","author":"Kuroki","year":"2020","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.ahj.2023.12.007_bib0025","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/europace\/euac148","article-title":"Novel cryoballoon ablation system for pulmonary vein isolation: multicenter assessment of efficacy and safety-ANTARCTICA study","volume":"24","author":"Heeger","year":"2022","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.ahj.2023.12.007_bib0026","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/europace\/euaa406","article-title":"Optimizing cryoballoon pulmonary vein isolation: lessons from >1000 procedures- the Frankfurt approach","volume":"23","author":"Bordignon","year":"2021","journal-title":"Europace"},{"issue":"11","key":"10.1016\/j.ahj.2023.12.007_bib0027","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jacep.2018.07.007","article-title":"Single-procedure outcomes and Quality-of-Life improvement 12 months post-cryoballoon ablation in persistent atrial fibrillation: results from the multicenter CRYO4PERSAF trial","volume":"4","author":"Boveda","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"11","key":"10.1016\/j.ahj.2023.12.007_bib0028","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.hrthm.2020.06.020","article-title":"Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: results from the multicenter STOP PersAF trial","volume":"17","author":"Su","year":"2020","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.ahj.2023.12.007_bib0029","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/europace\/euab281","article-title":"Cryoballoon vs. radiofrequency catheter ablation: insights from NOrwegian randomized study of PERSistent Atrial Fibrillation (NO-PERSAF study)","volume":"24","author":"Shi","year":"2022","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.ahj.2023.12.007_bib0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/europace\/eux275","article-title":"2017\u2009HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary","volume":"20","author":"Calkins","year":"2018","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.ahj.2023.12.007_bib0031","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/europace\/euac131","article-title":"The blanking period after atrial fibrillation ablation: an European Heart Rhythm Association survey on contemporary definition and management","volume":"24","author":"Bordignon","year":"2022","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.ahj.2023.12.007_bib0032","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003909","article-title":"Redefining the blanking period after catheter ablation for paroxysmal atrial fibrillation: insights from the ADVICE (Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination) trial","volume":"9","author":"Willems","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9","key":"10.1016\/j.ahj.2023.12.007_bib0033","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.hrthm.2021.06.1172","article-title":"Prevalence and outcome of early recurrence of atrial tachyarrhythmias in the cryoballoon vs irrigated radiofrequency catheter ablation (CIRCA-DOSE) study","volume":"18","author":"Steinberg","year":"2021","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.ahj.2023.12.007_bib0034","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/ije\/dym088","article-title":"Commentary: measuring the success of blinding in RCTs: don't, must, can't or needn't?","volume":"36","author":"Sackett","year":"2007","journal-title":"Int J Epidemiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323003538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323003538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:58:44Z","timestamp":1762077524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870323003538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":34,"alternative-id":["S0002870323003538"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.12.007","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of double-blinded, placebo-controlled interventional study for assessing catheter ablation efficacy in persistent atrial fibrillation: Insights from the ORBITA AF feasibility study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}